Contract Manufacturing & Private Label

We maintain a qualified network of GMP-certified manufacturing sites in Bangladesh, India, Egypt and other established pharmaceutical geographies, covering solid, liquid and semi-solid dosage forms. Site selection is never generic: we match your molecule to a plant by dosage form, capacity, cost base and — critically for this region — inspection history, because Central Asian registration requires GMP confirmation, and a site that has already passed an EAEU or national inspection saves months.

Technology transfer runs as a formal project: analytical method transfer, process validation batches, stability studies designed for regional climatic requirements, and a quality agreement that fixes responsibilities before the first commercial batch. Our quality team audits sites regularly and stands alongside the manufacturer in every inspection — and the economics are engineered backwards from the market, with cost of goods modelled against tender ceilings and retail price points before committing.

Safira also carries its own label. We select molecules from evidence — import statistics, tender histories, retail audit — then design the brand, packaging and dossier, place production at our audited sites and put Safira’s distribution and promotion machinery behind the launch. The same capability is available to partners who want an own-brand portfolio without building the infrastructure themselves.